Royalty Pharma(MX:RPRXN)
MX$1,213.520.00 (0.00%)
MX:RPRXN
Royalty Pharma earnings date
MX$1,213.52
At close:0.00 (0.00%)
Royalty Pharma (RPRXN) Q1 2026 Earnings Report
1 Followers
MX:RPRXN Q1 2026 EPS Results
- Actual EPS
- MXN 24.11
- Consensus EPS
- MXN 22.58
- Beat/Miss
- Beat by +MXN 1.53
- One Year Ago EPS
- MXN 13.93
MX:RPRXN Q1 2026 Revenue Results
- Actual Revenue
- MXN 11.73B
- Expected Revenue
- MXN 16.40B
- Beat/Miss
- Missed by -MXN 4.67B
- YoY Revenue Growth
- +10.97%
Earnings Announcement Details
- Quarter
- Q1 2026
- Date
- 05/06/2026
- Time
- Before Open
- Conference Call
- Wednesday, May 6, 2026
MX:RPRXN Upcoming Earnings
Royalty Pharma's next earnings date is estimated for February 16, 2027, based on past reporting schedules.
Q1 2026 Earnings Call Audio
MX:RPRXN Q1 2026 Earnings Call
0:00 / 0:00
Q1 2026 Earnings Slide Deck
Q1 2026 Earnings Call Summary
No earnings call summary is available for this earnings event.
MX:RPRXN Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Feb 16, 2027 | 2026 (Q4) | 29.13- | 27.27 | ― | ― |
| Nov 04, 2026 | 2026 (Q3) | 21.9722.47 | 21.82 | 2.98% (+0.65) | |
| Aug 05, 2026 | 2026 (Q2) | 23.6824.57 | 21.22 | 15.78% (+3.35) | |
| May 06, 2026 | 2026 (Q1) | 22.5824.11 | 13.93 | 73.03% (+10.17) | |
| Feb 11, 2026 | 2025 (Q4) | 23.9227.27 | 21.41 | 27.37% (+5.86) | |
| Nov 05, 2025 | 2025 (Q3) | 18.4921.82 | 17.06 | 27.92% (+4.76) | |
| Aug 06, 2025 | 2025 (Q2) | 19.2021.22 | 17.87 | 18.73% (+3.35) | |
| May 08, 2025 | 2025 (Q1) | 17.7313.93 | 18.19 | -23.42% (-4.26) | |
| Feb 11, 2025 | 2024 (Q4) | 19.6221.41 | 21.37 | 0.17% (+0.04) | |
| Nov 06, 2024 | 2024 (Q3) | 17.2417.06 | 14.68 | 16.22% (+2.38) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed


